Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
tyrosine/accident vascular cerebral
L'enllaç es desa al porta-retalls
15 resultats
Heterocyclic compounds useful as inhibitors of tyrosine kinases
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
This invention relates to substituted compounds of formula (I): ##STR2##
wherein Ar.sub.1, X, Y, P, Q and Het are defined below, which are useful as inhibitors of certain protein tyrosine kinases and are thus useful for treating diseases resulting from inappropriate cell
Heterocyclic compounds useful as inhibitors of tyrosine kinases
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
This invention relates to substituted compounds of formula (I): ##STR2##
wherein Ar.sub.1, X, Y, P, Q and Het are defined below, which are useful as inhibitors of certain protein tyrosine kinases and are thus useful for treating diseases resulting from inappropriate cell
Heterocyclic compounds useful as inhibitors of tyrosine kinases
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD OF THE INVENTION
This invention relates to substituted compounds of formula (I): ##STR2##
wherein Ar.sub.1, R.sub.a, R.sub.4, R.sub.5, X and Y are defined below, which are useful as inhibitors of certain protein tyrosine kinases and are thus useful for treating diseases resulting
Heterocyclic compounds useful as inhibitors of tyrosine kinases
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD OF THE INVENTION
This invention relates to substituted compounds of formula (I): ##STR2##
wherein Ar.sub.1, R.sub.a, R.sub.4, R.sub.5, X and Y are defined below, which are useful as inhibitors of certain protein tyrosine kinases and are thus useful for treating diseases resulting
Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This application claims priority to IT Patent Application No. TO2014A000806 filed Oct. 8, 2014, the entire content of which is hereby incorporated by reference.
FIELD OF THE INVENTION
The present description relates to compositions for use in the treatment of stroke in patients, particularly
Quinoline derivatives and their use as tyrosine kinase inhibitors
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention relates to quinoline derivatives and to the use thereof in therapy. More particularly, the present invention relates to quinoline derivatives for the treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke,
Quinoline derivatives and their use as tyrosine kinase inhibitors
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention relates to quinoline derivatives and to the use thereof in therapy. More particularly, the present invention relates to quinoline derivatives for the treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke,
Tyrosine-derived compounds as calcium channel antagonists
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to compounds that act to block calcium channels; methods of using the compounds to treat stroke, cerebral ischemia, pain, head trauma, or epilepsy; and to pharmaceutical compositions that contain the compounds of the
Tyrosine-derived compounds as calcium channel antagonists
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS REFERENCE
This application is a 371 of PCT/US99/12276 filed Jun. 2, 1999.
BACKGROUND OF THE INVENTION
FIELD OF THE INVENTION
The present invention relates to compounds that act to block calcium channels; methods of using the compounds to treat stroke, cerebral ischemia, pain, head trauma, or
Derivation of neural stem cells from embryonic stem cells
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD
The present invention relates generally to techniques for manipulating embryonic stem cells. More specifically, the invention relates to a method for derivation of neural stem cells (NSCs) from embryonic stem cells (ESCs) and the use of the ESC-derived NSCs to treat various neural
STEP-derived peptide for brain injury treatment
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
SEQUENCE LISTING
A sequence listing is submitted with the present application. The sequence listing is submitted as a .txt file entitled 7120107_SEQ_ST25.txt and is 12 kb in size. The entire contents of the sequence listing are hereby incorporated by reference.
BACKGROUND
Brain injury resulting from
STEP-derived peptide for brain injury treatment
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
SEQUENCE LISTING
A sequence listing is submitted with the present application. The sequence listing is submitted as a .txt file entitled 7120102_SEQ_ST25.txt and is 12 kb in size. The entire contents of the sequence listing are hereby incorporated by reference.
BACKGROUND
Brain injury resulting from
STEP-derived peptide for brain injury treatment
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
SEQUENCE LISTING
A sequence listing is submitted with the present application. The sequence listing is submitted as a .txt file entitled 7120107_SEQ_ST25.txt and is 12 kb in size. The entire contents of the sequence listing are hereby incorporated by reference.
BACKGROUND
Brain injury resulting from
Dipeptide mimetics of NGF and BDNF neurotrophins
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The invention relates to the field of bioorganic chemistry, namely to novel substituted dipeptides that are mimetics of the neurotrophic factors, which can be useful as pharmaceutical agents for the regulation of growth, differentiation, survival and programmed neuronal cell
Method and compositions for the treatment of neurological disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The present invention relates to novel synergistic pharmaceutical compositions and to a method for the treatment of certain neurological disorders in mammals including man. More particularly, the invention relates to novel pharmaceutical compositions and a method for alleviating ailments caused by a
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
